Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.44
0.00 (0.00%)
Apr 29, 2026, 9:58 AM EDT - Market open
Minerva Neurosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
282.34M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 79.59M |
| Compugen | 72.76M |
| Coherus Oncology | 42.17M |
| Editas Medicine | 40.52M |
| C4 Therapeutics | 35.95M |
| Zentalis Pharmaceuticals | 26.87M |
| LENZ Therapeutics | 19.09M |
| Abeona Therapeutics | 5.82M |
NERV News
- 26 days ago - Minerva Announces Leadership Transition - GlobeNewsWire
- 4 weeks ago - Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia - GlobeNewsWire
- 4 weeks ago - Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026 - GlobeNewsWire
- 6 weeks ago - Minerva Neurosciences Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - Minerva Neurosciences to Participate in The Citizens Life Sciences Conference - GlobeNewsWire